What is Unicycive Therapeutics, Inc. Common Stock's Market Cap?

Unicycive Therapeutics, Inc. Common Stock's Market Cap is $140.1M, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's Enterprise Value?

Unicycive Therapeutics, Inc. Common Stock's Enterprise Value is $85.5M, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's EV / EBITDA?

Unicycive Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's Net Income (TTM)?

Unicycive Therapeutics, Inc. Common Stock's Net Income (TTM) is -$39.9M, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's EBITDA?

Unicycive Therapeutics, Inc. Common Stock's EBITDA is -$29.9M, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Unicycive Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.

What is Unicycive Therapeutics, Inc. Common Stock's Net Debt?

Unicycive Therapeutics, Inc. Common Stock's Net Debt is -$54.6M, based on as-reported figures from SEC (XBRL) filings.

Unicycive Therapeutics, Inc. Common Stock (UNCY) Financial Statements

Unicycive Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG01163JH05

XNAS · usd

5.03▼ 0.13 (-2.52%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close5.16

Day's Range5.03 – 5.22

52-Week Range3.71 – 8.74

Volume784.3K

Avg Volume749.7K

Share Statistics

Shares Outstanding

Employees22

ExchangeXNAS

Listed2021-07-13

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Unicycive Therapeutics, Inc. Common Stock (UNCY)

What is Unicycive Therapeutics, Inc. Common Stock's Market Cap?: Unicycive Therapeutics, Inc. Common Stock's Market Cap is $140.1M, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's Enterprise Value?: Unicycive Therapeutics, Inc. Common Stock's Enterprise Value is $85.5M, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's EV / EBITDA?: Unicycive Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's Net Income (TTM)?: Unicycive Therapeutics, Inc. Common Stock's Net Income (TTM) is -$39.9M, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's EBITDA?: Unicycive Therapeutics, Inc. Common Stock's EBITDA is -$29.9M, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Unicycive Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.43, based on as-reported figures from SEC (XBRL) filings.
What is Unicycive Therapeutics, Inc. Common Stock's Net Debt?: Unicycive Therapeutics, Inc. Common Stock's Net Debt is -$54.6M, based on as-reported figures from SEC (XBRL) filings.